# Avid Bioservices Inc. (CDMO) Source: https://www.quantisnow.com/company/CDMO Generated: 2026-11-15T21:44:40.893Z - Ticker: CDMO - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - Website: avidbio.com ## About Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. ## Latest CDMO news and filings - 2025-02-18 11:07 UTC [SEC Form 15-12G filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-avid-bioservices-inc-5892609) - 2025-02-10 13:05 UTC [Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience](https://www.quantisnow.com/insight/avid-bioservices-launches-new-company-website-designed-to-boost-company-5878911) - 2025-02-08 00:40 UTC [SEC Form 4] [V. P., General Counsel Ziebell Mark R returned 66,799 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/v-p-general-counsel-ziebell-mark-r-returned-66799-shares-5878458) - 2025-02-08 00:40 UTC [SEC Form 4] [Director Thoma Jeanne returned 45,611 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-thoma-jeanne-returned-45611-shares-to-the-company-closing-5878457) - 2025-02-08 00:39 UTC [SEC Form 4] [Director Sargen Gregory returned 36,368 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-sargen-gregory-returned-36368-shares-to-the-company-closing-5878456) - 2025-02-08 00:39 UTC [SEC Form 4] [Chief Operations Officer Richieri Richard A. returned 58,320 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-operations-officer-richieri-richard-a-returned-58320-shares-to-5878455) - 2025-02-08 00:39 UTC [SEC Form 4] [Director Mackey Catherine J returned 43,379 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-mackey-catherine-j-returned-43379-shares-to-the-company-5878454) - 2025-02-08 00:38 UTC [SEC Form 4] [Chief Commercial Officer Kwietniak Matthew R. returned 50,796 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-kwietniak-matthew-r-returned-50796-shares-to-5878453) - 2025-02-08 00:38 UTC [SEC Form 4] [Chief Financial Officer Hart Daniel R returned 112,735 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-hart-daniel-r-returned-112735-shares-to-5878449) - 2025-02-08 00:38 UTC [SEC Form 4] [Director Hancock Richard B returned 124,191 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-hancock-richard-b-returned-124191-shares-to-the-company-5878448) - 2025-02-08 00:37 UTC [SEC Form 4] [President & CEO Green Nicholas Stewart returned 159,375 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-green-nicholas-stewart-returned-159375-shares-to-the-5878447) - 2025-02-08 00:37 UTC [SEC Form 4] [Director Carleone Joseph returned 130,324 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-carleone-joseph-returned-130324-shares-to-the-company-closing-5878446) - 2025-02-08 00:37 UTC [SEC Form 4] [Director Alegria Esther M. returned 37,746 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-alegria-esther-m-returned-37746-shares-to-the-company-5878445) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873702) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873696) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873693) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873692) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873691) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873690) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873689) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873688) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873687) - 2025-02-05 22:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avid-bioservices-inc-5873684) - 2025-02-05 22:06 UTC [SEC Form 8-K] [Amendment: Avid Bioservices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-avid-bioservices-inc-filed-sec-form-8-k-entry-into-5873646) - 2025-02-05 16:50 UTC [SEC Form 8-K] [Avid Bioservices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avid-bioservices-inc-filed-sec-form-8-k-entry-into-a-5872251) - 2025-02-05 15:45 UTC [Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger](https://www.quantisnow.com/insight/avid-bioservices-inc-provides-notice-of-fundamental-change-and-make-whole-5872211) - 2025-02-05 14:55 UTC [Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners](https://www.quantisnow.com/insight/avid-bioservices-poised-for-significant-growth-with-new-partners-gho-5872163) - 2025-01-30 22:01 UTC [SEC Form 8-K] [Avid Bioservices Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avid-bioservices-inc-filed-sec-form-8-k-submission-of-matters-5863904) - 2025-01-30 21:05 UTC [Avid Stockholders Approve Transaction with GHO and Ampersand](https://www.quantisnow.com/insight/avid-stockholders-approve-transaction-with-gho-and-ampersand-5863355) - 2025-01-30 00:39 UTC [SEC Form 4] [Director Hancock Richard B gifted 20,128 shares, decreasing direct ownership by 14% to 124,191 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hancock-richard-b-gifted-20128-shares-decreasing-direct-ownership-5862246) - 2025-01-23 22:04 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avid-bioservices-inc-5855757) - 2025-01-22 22:09 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avid-bioservices-inc-5853911) - 2025-01-22 21:05 UTC [Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand](https://www.quantisnow.com/insight/avid-reminds-stockholders-to-vote-today-for-the-transaction-with-5853396) - 2025-01-21 13:30 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avid-bioservices-inc-5851361) - 2025-01-21 13:00 UTC [Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand](https://www.quantisnow.com/insight/avid-recommends-stockholders-follow-recommendations-of-iss-and-glass-lewis-5851204) - 2025-01-14 00:33 UTC [SEC Form 4] [Chief Operations Officer Richieri Richard A. converted options into 5,971 shares and sold $30,715 worth of shares (2,483 units at $12.37), increasing direct ownership by 7% to 49,535 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operations-officer-richieri-richard-a-converted-options-into-5971-5844564) - 2025-01-08 22:20 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avid-bioservices-inc-5840041) - 2025-01-08 22:15 UTC [Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand](https://www.quantisnow.com/insight/avid-bioservices-files-investor-presentation-highlighting-value-maximizing-transaction-with-5840026) - 2025-01-08 21:50 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avid Bioservices Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avid-bioservices-inc-5839928) - 2025-01-03 00:05 UTC [SEC Form 4] [Chief Operations Officer Richieri Richard A. acquired $18,507 worth of shares (3,058 units at $6.05), increasing direct ownership by 4% to 46,311 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operations-officer-richieri-richard-a-acquired-18507-worth-of-5830036) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CDMO - Earnings history: https://www.quantisnow.com/earnings/CDMO - Dividend history: https://www.quantisnow.com/dividends/CDMO - Insider transactions: https://www.quantisnow.com/insiders/CDMO - Options chain: https://www.quantisnow.com/options/CDMO - SEC 8-K filings only: https://www.quantisnow.com/company/CDMO/8-k - RSS and alerts for CDMO: https://www.quantisnow.com/docs/rss-feeds.md